Brimonidine tartrate is the generic ingredient in nine branded drugs marketed by Padagis Israel, Galderma Labs Lp, Allergan, Akorn, Apotex, Bausch And Lomb, Indoco, Sandoz Inc, Somerset Theraps Llc, Teva Parenteral, Bausch And Lomb Inc, Alcon Labs Inc, Apotex Inc, and Watson Labs Teva and, and is included in twenty-two NDAs. There are thirty-four patents protecting this compound.
BRIMONIDINE TARTRATE drug price trends.
Drug patent litigation for BRIMONIDINE TARTRATE.
This ingredient has one hundred and thirty patent family members in thirty-one countries.
Twelve suppliers are listed for this compound. There are two tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
